Knight Therapeutics (TSE:GUD) Shares Down 0.8% - Here's What Happened

Key Points

• Knight Therapeutics Inc.'s stock fell 0.8%, trading between C$6.13 and C$6.18, with a significant drop in volume to approximately 45,983 shares, down 29% from the average.
• The company has a market cap of C$615.86 million, with financial ratios indicating a debt-to-equity ratio of 7.52 and a P/E ratio of -21.70.
• Specializing in pharmaceutical products, Knight Therapeutics focuses on developing, acquiring, and distributing both specialty and generic drugs in Canada and select international markets.

Knight Therapeutics Inc. (TSE:GUD - )'s stock price dropped 0.8% during mid-day trading on Monday . The company traded as low as C$6.13 and last traded at C$6.18. Approximately 45,983 shares traded hands during trading, a decline of 29% from the average daily volume of 65,105 shares. The stock had previously closed at C$6.23.

Knight Therapeutics Trading Down 0.8%

The company has a quick ratio of 1.79, a current ratio of 3.36 and a debt-to-equity ratio of 7.52. The company has a market cap of C$615.86 million, a P/E ratio of -21.70, a PEG ratio of -1,013.50 and a beta of 0.22. The business has a fifty day moving average price of C$6.30 and a 200-day moving average price of C$6.04.

About Knight Therapeutics

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.